| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.002 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.0039 | 1 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |